Eliem Therapeutics, Inc. Banner Image

Eliem Therapeutics, Inc.

  • Ticker ELYM
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
Eliem Therapeutics, Inc. Logo Image
  • 11-50 Employees
  • Based in Bellevue, Washington
Eliem Therapeutics, Inc. is a biotechnology company focused on developing novel therapies for neuronal excitability disorders to address unmet needs in psychiatry, epilepsy, chronic pain, and other disorders of the peripheral and central nervous systems. These disorders often occur when neurons are overly excited or inhibited, leading to an imbalance, and their focus is on restoring homeostasisMore. They are developing a pipeline of clinically differentiated product candidates focused on validated mechanisms of action with broad therapeutic potential to deliver improved therapeutics for patients with these disorders. Eliem channels its experience, energy, and passion for improving patients’ quality of life to fuel their efforts to develop life-changing novel therapies. At its core, the Eliem team is motivated by the promise of helping patients live happier, more fulfilling lives.
Eliem Therapeutics, Inc.

Most Recent Annual Report

Eliem Therapeutics, Inc.
MOST RECENT 2022 Annual Report and Form 10K

Older/Archived Annual Reports

Eliem Therapeutics, Inc. Logo Image

Rate This Report

Your vote helps our reports be more useful
Rating Saved!

Thank you for your feedback!